Follicle Stimulating Hormone Market to Grow with a CAGR of 5.76% through 2028
Increasing prevalence of
infertility and rising investment in research and development are factors
driving the global Follicle Stimulating Hormone market in the forecast period 2024-2028.
According to TechSci Research report, “Follicle
Stimulating Hormone Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Follicle
Stimulating Hormone Market stood at USD 1.20 billion in 2022 and is anticipated
to grow with a CAGR of 5.76% in the forecast period, 2024-2028. Follicle The Global Follicle Stimulating Hormone (FSH) Market has
experienced substantial growth in recent years, driven by various factors that
play a pivotal role in shaping the landscape of this industry. FSH is a vital
hormone in the human body, responsible for regulating reproductive processes.
Its significance in fertility treatment and the management of certain medical
conditions has propelled the FSH market into a dynamic and evolving space. One of the primary drivers of
the FSH market is the rising prevalence of infertility worldwide. Infertility
affects millions of couples globally, and FSH plays a crucial role in fertility
treatments such as in vitro fertilization (IVF) and assisted reproductive
technologies (ART). As infertility rates continue to rise due to various
factors, including lifestyle choices and delayed parenthood, the demand for
FSH-based therapies and medications also grows, thus boosting the market.
Technological advancements in the field
of assisted reproductive technologies have transformed the landscape of
fertility treatments. Techniques like IVF, intracytoplasmic sperm injection
(ICSI), and intrauterine insemination (IUI) have become more accessible and
successful. FSH is a key component in these treatments, stimulating the
development of multiple follicles in the ovaries. As these technologies
continue to evolve and improve success rates, the demand for FSH products rises
in tandem. The world's population is aging at an
unprecedented rate. An aging population is associated with a higher incidence
of age-related fertility issues, such as diminished ovarian reserve and an
increased risk of chromosomal abnormalities in embryos. FSH is often prescribed
to women of advanced maternal age to enhance their chances of conceiving. As
the number of individuals seeking to have children at older ages increases, so
does the demand for FSH treatments.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC
on "Global Follicle Stimulating Hormone Market.”
While FSH is predominantly associated
with fertility treatments, it has also found applications in non-fertility
indications. For instance, FSH is used in the management of certain medical
conditions, such as hypogonadism and Turner syndrome. The diversification of
FSH applications beyond fertility contributes to the growth of the FSH market,
as it opens up new avenues for product development and revenue generation.
The Global Follicle Stimulating Hormone Market is
segmented Type, Application and company. Based on Type, the Recombinant FSH segment has
emerged as the predominant market leader. The growing prevalence of infertility issues and the
rising trend of delayed childbearing have led to an increased demand for
fertility treatments, including IVF, where FSH is a critical component. Ongoing
research and development in biotechnology have allowed for the improvement of
recombinant FSH formulations, making them more effective and convenient for
patients. Based on region, North America segment is expected to
grow during the forecast period. North America's dominance in the
global Follicle Stimulating Hormone market can be attributed to its advanced
healthcare infrastructure, increasing prevalence of infertility, and a
proactive approach to research and development. The region's leadership in this
market not only drives economic growth but also brings hope to individuals and
couples struggling with reproductive issues worldwide. As FSH treatments
continue to evolve, North America is poised to remain at the forefront of
reproductive healthcare innovation, benefiting patients across the globe.
The Asia Pacific region is experiencing rapid market
growth. The region leads in pharmaceutical research and development. Many
pharmaceutical companies in the region are actively involved in innovating FSH
formulations and delivery methods, making them more effective and patient
friendly.
Major companies operating in Global Follicle
Stimulating Hormone Market are:
- Merck Serono
- Creative BioMart inc.
- Midas Pharma GmbH
- GenPharm
- Trumac Healthcare pvt ltd
- LIVZON PHARMACEUTICAL GROUP INC
- Shanghai Techwell Biopharmaceutical Co.,
Ltd.
- Merck Sharp & Dohme Corp
- Lee Biosolutions,Inc
- BIOGENIX INC.PVT.LTD.
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global Follicle Stimulating Hormone Market is on
a growth trajectory, primarily driven by factors such as the increasing
prevalence of infertility, advancements in assisted reproductive technologies,
the aging population, expanding non-fertility applications, growing awareness
and education, and a supportive regulatory environment. As these market drivers
continue to shape the landscape of the FSH market, it is likely that the
industry will experience sustained growth in the coming years.,” said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based management
consulting firm.
“Follicle Stimulating Hormone Market Type ( Recombinant FSH,
Urinary FSH), By Application (Infertility Treatment, Assisted Reproductive
Application (ART), Others), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Follicle Stimulating Hormone Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Follicle Stimulating Hormone Market.
Contact
Mr. Ken Mathews
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel:
+13322586602
Email:
[email protected]
Website:
www.techsciresearch.com